Cargando…
Recombinant anti-human epidermal growth factor receptor type 2 single-chain variable fragment-alpha-luffin fusion protein as a putative immunotoxin against human epidermal growth factor receptor type 2-positive breast cancer cells: an experimental research
BACKGROUND: Breast cancer is one of the most frequent causes of cancer death in women. The application of immunotoxins to target overexpressed biomarkers on the surface of cancer cells and delivery of the toxin molecules into these cells has attracted too much attention during the last decade. OBJEC...
Autores principales: | Damough, Shadi, Bayat, Elham, Oghabi Bakhshaiesh, Tayebeh, Barkhordari, Farzaneh, Esmaeili, Rezvan, Nematollahi, Leila, Talebkhan, Yeganeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473382/ https://www.ncbi.nlm.nih.gov/pubmed/37663730 http://dx.doi.org/10.1097/MS9.0000000000000731 |
Ejemplares similares
-
Optimization of EnBase Fed-Batch Cultivation to Improve Soluble Fraction Ratio of α-Luffin Ribosome Inactivating Protein
por: Barkhordari, Farzaneh, et al.
Publicado: (2018) -
Immunotoxin Therapies for the Treatment of Epidermal Growth Factor Receptor-Dependent Cancers
por: Simon, Nathan, et al.
Publicado: (2016) -
Vitamin D and breast cancer risk: A systematic review and meta-analysis in Iranian patients
por: Oghabi Bakhshaiesh, Tayebeh, et al.
Publicado: (2022) -
Targeting pediatric sarcoma with a bispecific ligand immunotoxin targeting urokinase and epidermal growth factor receptors
por: Pilbeam, Kristy, et al.
Publicado: (2017) -
Comparison of epidermal growth factor receptor tyrosine kinase inhibitors for patients with lung adenocarcinoma harboring different epidermal growth factor receptor mutation types
por: Park, Sojung, et al.
Publicado: (2021)